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ABSTRACT
The objective of this study was to assess the effectiveness of the 5A’s smoking cessation intervention (5A’s) to that of brief 
advice (BA) conducted by dentists. A single-blinded randomized controlled trial was designed to compare the effectiveness 
of the interventions. Six Dental Public Health specialists were recruited, randomized and trained to participate in this 
trial. Two hundred and fifty patients were required on both arms. The main outcome measures were biochemically 
validated self-reported abstinence and behaviour change at 6-months follow-up. The odd of quitters in 5A’s intervention 
was 3.81 (95% CI: 1.87-7.76; p= 0.00) times higher compared to BA. After controlling other factors, the odds ratio for 
the 5A’s was 1.90 (95% CI: 0.652-5.547; p=0.24) higher compared to BA. The 5A’s was found to be more effective in 
initiating positive behaviour change compared to BA. However, after controlling other factors, there was no difference 
in the effectiveness although the odds ratio was slightly higher in 5A’s. 
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ABSTRAK
Objektif kajian ini adalah untuk menilai keberkesanan intervensi berhenti merokok 5A’s (5A’s) berbanding nasihat ringkas 
(BA) yang disampaikan oleh doktor pergigian dalam klinik pergigian. Satu percubaan klinikal terkawal rawak untuk 
membandingkan keberkesanan 5A’s berbanding BA. Enam pakar Kesihatan Awam Pergigian telah dikenal pasti secara 
rawak dan dilatih untuk mengambil bahagian dalam kajian ini. Dua ratus lima puluh pesakit diperlukan untuk setiap 
intervensi. Keputusan utama kajian adalah berhenti merokok yang disahkan secara biokimia dan perubahan tingkah 
laku pada rawatan susulan selepas 6 bulan. Dalam ujian klinikal, nisbah kemungkinan pesakit yang berhenti merokok 
dalam 5A’s adalah 3.81 (95% CI: 1,871-7, 76; p= 0.00) kali lebih tinggi berbanding BA. Selepas mengawal faktor lain, 
nisbah kemungkinan bagi 5A’s adalah 1.90 (95% CI: 0,652-5,547; p=0.24) lebih tinggi berbanding BA. 5A’s didapati lebih 
berkesan dalam memulakan perubahan tingkah laku positif berbanding BA. Walau bagaimanapun, selepas mengawal 
faktor lain, tidak ada perbezaan dalam keberkesanan walaupun nisbah kemungkinan yang lebih tinggi sedikit pada 5’As. 
Kata kunci: Berhenti merokok; berhenti tembakau; doktor pergigian; nasihat ringkas
INTRODUCTION
Tobacco is the major cause of preventable mortality and 
morbidity all over the world (World Health Organization 
2010). One of the globally accepted roles of dentists in 
prevention and health promotion is helping tobacco users 
to quit and tobacco cessation should be part of the practice 
of dentistry (Gallagher et al. 2010). A large number of 
oral diseases and conditions such as staining of teeth and 
restorations, halitosis, impaired wound healing, periodontal 
diseases, failure of implants and surgical treatments, acute 
necrotizing ulcerative gingivitis and life-threatening 
precancerous and cancerous lesions are attributed to 
smoking (Warnakulasuriya et al. 2010). In England and 
Wales, Unal et al. (2004) reported that between 1981 and 
2000, more than half of the decrease in coronary heart 
disease mortality was being the reduction in smoking. 
This finding shows that smoking is a common risk factor 
(Watt & Sheiham 2012) for coronary heart disease and 
periodontitis (or any tobacco related oral conditions) and 
that offering smoking cessation in the dental practice 
will impact upon patients both oral and systemic disease 
risk. Therefore, the involvement of primary dental care in 
smoking cessation will help contribute to a wider nationally 
coordinated tobacco control strategy (Croucher 2005).
 A range of guidelines has been published globally 
to encourage health professionals including dentists, to 
deliver effective cessation advice and support (Beaglehole 
& Benzian 2005; Beaglehole & Watt 2004; Fiore et al. 
2008; West et al. 2000; World Health Organization 2010). 
Dental care settings represent a clinical opportunity where 
patients may be receptive to cessation advice and assistance 
particularly if their oral health concerns can be related to 
tobacco use (Gordon et al. 2006). However, adoption of the 
5A’s (Ask, Advice, Assess, Assist, Arrange) in the routine 
dental care has been slow (Hu et al. 2006; Needleman et al. 
2006; Warnakulasuriya 2002). Again as discussed earlier, 
the practice of the 5A’s has limitations. Dentists have 
accepted the responsibility of the first two A’s- Ask and 
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Advice, but reluctant to assess interest, assist and follow 
up due to time-consuming and limited knowledge (Gordon 
et al. 2006). However, there is no definitive conclusion 
about what a best practice model should look like or 
practically effective particularly for its implementation in 
the dental setting (Dawson et al. 2013). As time constraint 
is the commonly cited reason for not conducting smoking 
cessation intervention, comparing the 5A’s model with the 
brief advice could provide understandings into the tensions 
and realities of providing chairside smoking cessation 
intervention.
 In Malaysia, the standard of practice policy on 
smoking cessation intervention in the dental practice is 
unavailable. Currently, in the Ministry of Health Malaysia, 
dentists practiced the 5A’s approach using the Malaysian 
Clinical Practice Guideline for Treatment of Tobacco 
Dependence 2003. However, most dentists refer their 
dental patients who want to quit smoking to the existing 
Quit Smoking Clinic located in most Health Centres in the 
Ministry of Health. Consequently, in Malaysia, the recent 
National Oral Health Plan for 2011-2020, provision for 
the first time for dental professionals to participate in and 
contribute to the success of the Ministry of Health’s efforts 
in providing some form of care and advice to their patients 
against smoking (Oral Health Division 2011). However, the 
lack of time and expertise are cited commonly by dentists 
as barriers to undertaking this intervention (Dawson et al. 
2013). 
 A simpler brief advice intervention (Coleman 2004; 
Lando et al. 2007) could offer important insights for it to 
be explored as a suitable method for chairside smoking 
cessation intervention in the dental setting. Although in 
Malaysia, there were dentists trained either from their 
undergraduate institution (Yahya et al. 2012) or on the 
job training (Amer Nordin et al. 2014), to relate patients’ 
tobacco-use with their oral health diseases and to advise 
them to quit, there is still limited data on the acceptability, 
feasibility and effectiveness of the smoking cessation 
intervention given. Therefore, the objective in this study 
was to assess the effectiveness of the 5A’s smoking 
cessation intervention (5A’s) to that of brief advice (BA) 
which dentists delivered in a dental setting. 
MATERIALS AND METHODS
This study was a single-blinded randomized controlled trial 
(parallel design) designed to compare the effectiveness 
of the 5A’s smoking cessation intervention (5A’s) to that 
of brief advice (BA) which dentists delivered in a dental 
setting. The primary outcome in this trial was prolonged 
abstinence of 30 days (Velicer & Prochaska 2004) as 
a self-reported outcome measure and a piCO+ carbon 
monoxide (CO) monitor to validate abstinence at the six-
month follow-up.
 Ethical clearances were obtained from the Research 
Ethics Committee of the University of Malaya’s Faculty of 
Dentistry and the Ministry of Health Malaysia’s Medical 
Research Ethics Committee (MREC). This trial is also 
registered with the National Medical Research Register 
(NMRR) (Registration number: NMRR-13-406-15721) and 
the International Standard Randomised Controlled Trial 
Number (ISRCTN) registry (Registration number: ISRCTN 
16325841) a primary clinical trial registry recognised by 
the World Health Organization (WHO) International Clinical 
Trials Registry Platform (ICTRP) and the International 
Committee of Medical Journal Editors (ICMJE). 
 There were two samples involved in this trial. First was 
the healthcare provider which conducted the clinical trial. 
Secondly were the patients who attended dental clinics 
for dental treatment, enrolled to participate in this trial. 
Dental Public Health (DPH) specialists in Selangor state 
were recruited as healthcare providers to deliver smoking 
cessation interventions in this study. The decision was 
based on the probability that the turnover rates would be 
high if general dentists were be recruited for the study. 
Therefore, out of 14 DPH specialists in Selangor, only 6 
met the inclusion criteria. The inclusion criteria were DPH 
specialists with five or more years of working experience 
who were posted at the main district clinic, were interested 
in this research project and were not involved in other 
research projects with other organizations. DPH specialists 
who served as the main administrators (deputy directors) 
or whose main clinics were located remotely from the city 
centre of Kuala Lumpur and those who planned to retire 
within the two-year period were excluded from the study.
 The six DPH specialists who participated in this study 
were randomized equally into two intervention groups by 
the drawing of lots. One group was devoted to the 5A’s (3 
DPH specialists) and the other was devoted to brief advice 
intervention (3 DPH specialists). The estimated sample size 
of patients for this study was calculated with α value of 
0.05 and desired power of 0.80. It was calculated that 226 
patients were required on both arms. The final sample size 
estimated was 250 patients on both arms after taking 10% 
dropouts into consideration.
 Patients enrolled did not know which interventions 
they received. All dental clinics enrolled patients into this 
study for a minimum of six months. Each DPH specialist 
enrolled patients who fulfilled the inclusion criteria into 
the assigned smoking cessation intervention program. The 
inclusion criteria were: smokers who attended Ministry 
of Health Dental Clinics in Selangor and smoked at least 
one cigarette in 30 days; Malaysian citizens; Adults aged 
between 15 and 70 years (this age range was adapted 
from the Malaysian Global Adult Tobacco Survey (GATS) 
in 2011 (Institute for Public Health 2012), a nationally 
representative household survey of noninstitutionalized 
men and women aged 15 years or older); Those who are 
contactable via a mobile phone or a landline; and Those 
who are not currently undergoing smoking cessation 
treatment with other health clinics.
 A smoking cessation training workshop was held 
to train and standardize the DPH specialists in each 
intervention group on two separate dates. After the training, 
all DPH specialists involved were briefed on the clinical trial 
protocols. The specialists received kits containing tobacco 
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use assessment sheets, pamphlets and carbon monoxide 
(CO) monitors after the training in order to conduct the 
intervention in their respective dental clinics. 
 At baseline for both intervention groups, patients’ 
tobacco use and nicotine dependence were assessed 
and recorded. All patients were asked on when they 
started smoking, how long they had smoked the number 
of cigarettes they smoked in a day and the amount of 
money they spent on cigarettes in a month. They were 
also questioned about their previous quit attempts, 
asked to identify what their single major reason for 
quitting smoking would be and asked to name one major 
barrier to their efforts to quit smoking. Any oral health 
conditions associated with the patient were also recorded 
in the assessment form. These oral health conditions were 
subsequently used to personalise the advice that the DPH 
specialists gave patients to help them quit smoking.
 Nicotine dependence was assessed using the 
Fagerström Test for Nicotine Dependence (FTND) 
questionnaire (Anne Yee et al. 2011; Heatherton et al. 
1991). The levels of CO in patients’ lungs were recorded 
using the piCO+ CO monitor. Each patient was asked to 
select one statement using the Contemplation Ladder 
questionnaire (Biener & Abrams 1991) that best fit his or 
her readiness to quit smoking. Based on the answer, the 
patient’s stage of change was determined. 
 DPH specialists in the 5A’s intervention group 
conducted the trial using the five steps in the 5A’s 
intervention developed by Fiore et al. (2008). Patients 
in the 5A’s group subsequently received assistance 
appropriate to his or her stage of change. Patients who 
were at the pre-contemplation and contemplation stages 
of change, the 5R’s strategies (Fiore et al. 2008) were 
applied to increase their motivation to quit smoking. The 
5R’s constitute a motivational counselling intervention that 
emphasizes the following: Relevance to the patient, risks 
of smoking, rewards of quitting, roadblocks to quitting 
and repetition. The intervention involved talking about 
smoking and quitting and then reinforcing the points 
most likely to motivate patients to quit. Patients in the 
preparation stage were advised on the behavioral strategies 
that would help them cope with withdrawal symptoms and 
prevent relapses. They were given self-help pamphlets and 
encouraged to set a quit date within two weeks of their first 
visit. 
 For the BA group, each patient received a brief advice 
message to quit smoking (1-5 min) (Coleman 2004; Lando 
et al. 2007) regardless of at which stage they are in the 
stage of change. All patients from both intervention groups 
did not receive any nicotine replacement therapy (NRT), 
Varenicline, or other drugs during this intervention.
 Patients from both intervention groups were followed 
up via telephone one month and three months after the 
first visit. During the six-month follow-up, patients 
from both groups were called for appointments with the 
respective DPH specialists in the dental clinic. The patients’ 
stages of change were assessed using the Contemplation 
Ladder questionnaire. Each patient was asked to select 
one statement that best fit his or her readiness to quit 
smoking. Based on the answer given, the patient’s stage 
of change was determined. Patients were also questioned 
about their quitting methods, which are, whether they quit 
cold turkey, gradually decreased the number of cigarettes, 
or made no quit attempt. The levels of carbon monoxide 
in the patients’ lungs were recorded using the piCO+ CO 
monitor to validate patients’ self-reported abstinence.
 All patients recruited from both groups were included 
in the intention-to-treat analysis for all follow-ups. A 
descriptive analysis was performed first, with categorical 
variables expressed as proportions and continuous 
variables as mean (SD). Multivariate logistic regression 
was used to predict abstinence at the six-month follow-up. 
The demographic variables and the smoking characteristics 
were entered in a multivariable stepwise multiple logistic 
regression model to determine the odds ratios (OR) and 95% 
confidence intervals (95% CI) for abstinence. A probability 
value of p<0.05 was reported as significant.
RESULTS
There were 193 patients participated for the 5A’s group and 
207 patients for the BA group (Figure 1). Retention rates 
at 1-month follow-up were 65.3% (drop-out= 34.7%) for 
5A’s group and 79.2% (drop-out= 20.8%) for BA group. 
Retention rates at 3-month follow-up were 53.9% (drop-
out= 46.1%) for 5A’s group and 71.5% (drop-out= 28.5%) 
for BA group. Retention rates at 6-month follow-up were 
33.2% (drop-out= 66.8%) for 5A’s group and 38.2% (drop-
out= 61.8%) for BA group. All patients who were lost to 
follow-up were mostly not contactable through telephone 
call either for the 1-month, 3-months follow-up or to make 
an appointment for the 6-months follow-up in the clinic. 
None claimed to withdraw or declined to participate in the 
trial during the follow-ups. All patients recruited from both 
groups were included in the intention-to-treat analysis for 
all follow-ups. 
 Table 1 shows the social characteristics of participants 
for 5A’s and BA smoking cessation interventions. The 
mean age for participants in the 5A’s group was 26.07 
±12.12 years old. The mean age for participants in the BA 
group was 35.38 ±10.24 years old. There was a significant 
difference in the age of participants between the 5A’s and 
the BA interventions (p<0.001). Most participants in both 
interventions were males (5A’s n=190, 98.4%; BA n=207, 
100%), Malays (5A’s n=178, 92.2%; BA n=180, 87%) and 
have the highest level of education of secondary school 
(5A’s n=140, 72.5%; BA n=114, 55.1%). Chi squared test 
showed a significant difference in the participants’ level 
of education (p<0.001). A significant difference (p<0.001) 
was similarly observed in terms of marital status whereby; 
most participants in the 5A’s group were single (n=117, 
60.7%), while most participants the BA group were married 
(n=153, 73.9%). 
 Table 2 describes the smoking characteristics and 
nicotine dependence of participants in the 5A’s and 
BA smoking cessation interventions. The mean age of 
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FIGURE 1. Flow Diagram of the Dental Public Health Specialists and participants in 
the 5A’s model group and the BA group. Adapted from CONSORT (2010)
TABLE 1. Social characteristics of participants enrolled for 5A’s model 
and BA smoking cessation interventions 
Characteristics
Types of smoking cessation 
intervention p-value
5As (N=193) BA (N=207)
Age (years) Mean ±SD 26.07 ± 12.12 35.38 ± 10.24 p<0.001a
Gender:
 Male, n (%)
 Female, n (%)
190 (98.4)
3 (1.6)
207 (100)
0 (0) 0.230b
Ethnic:
 Malay, n (%)
 Chinese/Others, n (%)
 Indian, n (%)
178 (92.2)
2 (1)
13 (6.74)
180 (87)
15 (7.2)
12 (5.8) 0.009 b
Marital status:
 Single, n (%)
 Married, n (%)
117 (60.7)
76 (39.4)
53 (25.6)
153 (73.9) p<0.001 b
Highest level of education:
 Primary school, n (%)
 Secondary school, n (%)
 Certificate/Diploma, n (%)
 Degree, n (%)
3 (1.6)
140 (72.5)
32 (16.6)
16 (8.3)
22 (10.6)
114 (55.1)
51 (24.6)
6 (2.9) p<0.001 b
a Mann-Whitney U test ; b χ2 test
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participants started smoking were significantly younger 
in the 5A’s group (14.92± 3.11 years old) compared to 
participants in the BA group (17.71 ±4.02 years old). The 
mean duration of being a smoker was significantly shorter 
for 5A’s (11.35 ±10.23 years) compared to BA (17.40 ±9.94 
years). All participants enrolled for both interventions were 
mostly cigarette smokers. The mean number of cigarettes 
taken by the smokers per day was 9.94 ± 8.3 sticks for 
5A’s while for BA was 11.60 ±7.86 sticks. The difference 
was statistically significant (p=0.042). The participants in 
the BA group spent more money on cigarettes per month, 
which was 169.43 ± 129.68 MYR compared to 5A’s group 
(147.09 ± 121.96 MYR). However, the difference was 
not statistically significant (p=0.085). The proportion of 
participants with high level of CO in lungs was significantly 
higher in the BA group than the 5A’s group.
 Table 3 shows the participants abstinence rate at 
1-month, 3-months and 6-months follow-up. Chi-squared 
test showed a statistically significant difference between 
the smoking cessation interventions and abstinence of 
participants at 1-months (p=0.006), 3-months (p=0.015) 
and 6-months of follow-up (p<0.001). The rate of 
abstinence increased at 1-month and 3-months follow-
up for both interventions. However, quitting decreased 
by 1.1% for 5A’s group and by 4.8% for BA group at 
6-months follow-up. Only 34 (17.6%) participants in 5A’s 
group quit smoking compared to 11 (5.3%) participants 
in BA group at 6-months follow-up. The percentage of 
TABLE 2. Smoking characteristics and nicotine dependence of participants in 
5A’s and BA smoking cessation interventions
Characteristics
Types of smoking cessation intervention
p-value5A’s (N=193) BA (N=207)
Age started smoking (years)
 Mean ±SD 14.92 ± 3.11 17.71 ± 4.02 p<0.001a
Duration of smoking (years)
 Mean ±SD 11.35 ± 10.23 17.40 ± 9.94 p<0.001a
No. of cigarettes per day (sticks)
 Mean ±SD 9.94 ± 8.3 11.60 ± 7.86 0.042 a
Money spent per month (RM)
 Mean ±SD 147.09 ± 121.96 169.43 ± 129.68 0.085 a
Tried quitting before:
 Yes, n (%)
 No, n (%)
165 (85.5)
28 (14.5)
173 (83.6)
34 (16.4) 0.348 b
If Yes, how many times?
 Mean ±SD 2.73 ± 3.07 2.35 ± 2.10 0.161 a
cLevel of nicotine addiction:
 Very low dependence, n (%)
 Low dependence, n (%)
 Moderate dependence, n (%)
 High dependence, n (%)
107 (55.4)
46 (23.8)
18 (9.3)
15 (7.8)
129 (62.3)
50 (24.2)
11 (5.3)
17 (8.2) 0.404 b
dLevel of CO in lungs:
 Low (1-6ppm), n (%)
 Moderate (7-10ppm), n (%)
 High (11ppm or more), n (%)
38 (19.7)
47 (24.4)
108 (56.0)
17 (8.2)
41 (19.8)
149 (72.0) 0.001 b
a Mann-Whitney U test; b χ2 test
c Fagerström test for nicotine dependence (FTND) ; d CO breath analyser 
TABLE 3. Abstinence at 1-month, 3-months and 6-months follow-up for BA 
and 5A’s model of smoking cessation interventions
 Interventions
Abstinence from smoking 
1-month
n (%)
3-months
n (%)
6-months
n (%)
Quit No quit Quit No quit Quit No quit
5A’s (N=193) 32 (16.6) 161 (83.4) 36 (18.7) 157 (81.3) 34 (17.6) 159 (82.4)
BA (N=207) 16 (7.7) 191 (92.3) 21 (10.1) 186 (89.9) 11 (5.3) 196 (94.5)
χ2 p value 0.006 0.015 <0.001
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participants with no abstinence for both interventions was 
seen decreasing during the 3-months follow-up. However, 
at 6-months follow-up, the trend increases slightly for both 
interventions. About 94.5% (n=196) of participants in the 
BA group did not quit smoking compared to 82.4% (n=159) 
of participants in the 5A’s group.
 Table 4 categorizes smokers according to the level of 
carbon monoxide breath analysis. Sixty-four participants 
from the 5A’s group and 79 participants from the BA 
group came for follow-up at 6-months in the dental clinic. 
Therefore, only these participants were able to conduct the 
biochemical validation test for abstinence. A statistically 
significance was seen for each intervention between the 
type of smokers and quitting (p< .0001). The strength of 
this trial was the use of a confirmative evaluation of the 
smoking cessation interventions with a comparison of 
abstinence verified chemically using a carbon monoxide 
analyser on an intent-to-treat basis. A cut off point of more 
than 11 ppm of CO is considered as a smoker, 7-10 ppm 
as a light smoker and 0-6 ppm as a non-smoker (Bedfont 
Scientific Ltd. 2012). It was observed that participants 
who quitted had a low CO level in their lungs (0-6 ppm). 
However, some quitters had 7-10 ppm of CO levels; this 
may be due to the exposure to air polluted with CO such 
as car exhaust at their workplace or home.
 Table 5 shows the predictors of quitting at 6-months 
follow-up using binary logistic regression. A binary logistic 
regression analysis using abstinence at 6-months follow-
up as the dichotomous criterion variable (code 0=no quit; 
code1= quit) and type of smoking cessation interventions 
(5A’s and BA) as predictor variable were carried out. The 
OR (95% CI) for those who quit in the 5A’s group was 
3.81(1.871-7.76) higher compared to BA. There was a 
statistically significant difference between the smoking 
cessation interventions and quitting (p<0.001). Therefore, 
the types of intervention did predict quitting at 6 months 
follow-up as shown in model 1 in Table 5. 
 When the social demographic variables (age, ethnic, 
marital status and highest level of education) were 
controlled, the OR (95% CI) for the 5A’s was 2.11(0.917-
4.889) higher compared to BA. Nonetheless, there was 
no significant difference between the smoking cessation 
interventions and quitting after controlling age, ethnic, 
marital status, and highest level of education as shown in 
Model 2 (Table 5). Finally, the smoking characteristics of 
the participants (age started smoking, duration of smoking, 
number of cigarettes taken per day, money spent per month, 
tried quitting before, FTND and level of CO in lungs) were 
added to create the third model. In this model, the OR (95% 
CI) for the 5A’s was 1.90 (0.652-5.547) higher compared 
to BA. Again, there was no significant difference found 
between the smoking cessation interventions and quitting 
after controlling social demographic variables and smoking 
characteristics of the participants (Table 5). Only the level 
of CO in lungs was significant. 
DISCUSSION
The unit of randomization in this trial was the DPH 
specialists and their age range was 49 to 54 years old; five 
were females and had clinical practice experience of 25 to 
30 years. As these specialists were assigned to different 
clinics, thus this was similar to 5 dental offices studies 
in the Carr and Ebbert review (2011) where the dental 
office was the unit of randomization. However, the 6 DPH 
specialists were trained and standardized according to the 
smoking cessation interventions they were allocated to, 
and followed strict clinical protocol. A post hoc subgroup 
analysis of studies conducted in dental practices (settings) 
found that a minimum brief counselling to adult smokers 
showed a significant benefit of intervention compared to 
usual care or less treatment intensive controls with no 
evidence of heterogeneity (Carr & Ebbert 2011). Apart 
from the smoking cessation interventions, the specialists in 
this trial conducted routine oral examination, personalised 
counselling from the examination as to oral effects to 
tobacco use, and self-help materials in accordance with 
the majority of the studies reported in the Cochrane review 
(Carr & Ebbert 2011).
 Smokers participated in this trial were mostly men, 
middle-aged, had high nicotine dependency and wanting 
to stop smoking mainly for health reasons. The majority 
of men participated in this trial may reflected the 43.9% 
(4.64 million) of Malaysian men aged 15 years or older 
were current cigarette smokers in 2011 and only 1.0% (0.10 
million) are women from a national survey (Institute for 
Public Health 2012). A similar result was also reflected 
by Wee et al. (2011), where most smokers were male 
TABLE 4. Level of carbon monoxide (ppm) at 6-months follow-up for BA and 5A’s 
model of smoking cessation interventions
Interventions
Level of carbon monoxide (ppm)
P-value0-6 ppm(Non-smoker)
n (%)
7-10 ppm
(Light smoker)
n (%)
>11 ppm
(Smoker)
n (%)
Total
n(%)
5A’s (N=64) Quit
No quit
29 (51.8)
9 (16.1)
4 (7.1)
12 (21.4)
0 (0)
10 (18.0)
33(51.6)
23(36.0)
<0.001
BA (N=79) Quit
No quit
8 (10.1)
9 (11.4)
3 (3.8)
18 (22.8)
0 (0)
41(51.9)
11(14.0)
68(86.1)
<0.001
  137
but again these data were collected in a health setting. 
Nonetheless, a study in Japan by Hanioka et al. (2010) 
found the smokers attended quit smoking clinics in dental 
clinic were predominantly male. However, trials conducted 
by other studies (Gordon et al. 2007; Nohlert et al. 2009) 
recruited more females due to the fact that women were 
more willing to seek and accept support for smoking 
cessation compared to men.
 In this study, abstinence during all follow-ups was 
significantly found to be higher for participants in the 5A’s 
group compared to BA group. However, the data fluctuate 
with increasing number of patients with 7-day abstinence 
at 3-month but later decreased at 6-month follow-up. 
However, after controlling for age, ethnic, marital status 
and level of education, patients in the 5A’s group was 2.11 
times likely to quit at 6-month compared to brief advice, 
but was not statistically significant. Consequently, when the 
smoking characteristics of smokers were controlled, only 
the type of smoker (level of CO in lungs) had a statistically 
significant influence on the probability of abstinence 
at 6-month follow-up. At this time, patients in the 5A’s 
group were 1.9 times likely to quit at 6-month compared 
to brief advice but was also not statistically significant. 
These results were similar to a US study comparing 5A’s 
and 3A’s, where more patients quitted in the 5A’s condition 
than those in the 3A’s but was not significant (Gordon et 
al. 2007). The higher abstinence in the 5A’s group were 
because the 5A’s behavioural therapy in this study assessed 
participants’ readiness to change as a guide to identify 
which appropriate method to apply on patients to assist 
them to quit smoking. On the contrary, BA only provides 
brief advice regardless of assessing participants’ readiness 
to change. This is due to the following reasons pertaining 
to the behavioural therapy aspects. 
 Firstly, using the stage of change as a guide in the 
step- assess in 5A’s, participants in the preparation stage 
allows them to decide to commit to making changes, ready 
to start taking action in the future or likewise. Motivational 
questions propose to smokers opportunistically even in the 
dental setting may trigger and can initiate them to decide to 
quit smoking. However, as stated by Báezconde-Garbanati 
et al. (2011), the plans to quit at preparation stage should 
TABLE 5. Predictors of abstinence at 6-months follow-up using binary logistic regression
Variables Model 1
OR (95% CI)
p-value Model 2
OR (95% CI)
p-value Model 3
OR (95% CI)
p-value
Interventions:
 BA(reference)
 5A’s
3.81(1.871-7.76) <0.001 2.11(0.917-4.889) 0.079 1.90(0.652-5.547) 0.240
Age 1.044(0.989-1.103) 0.117 1.126(0.846-1.499) 0.416
Ethnic:
 Malay (reference)
 Others
0.872(0.277-2.748) 0.815 0.550 (0.109-2.780) 0.470
Marital status:
 Single (reference)
 Married
0.583(0.198-1.713) 0.326 0.407(0.106-1.569) 0.192
Highest level of education:
 Primary/SecondarySchool (reference)
 Diploma/Degree
0.856(0.378-1.935) 0.708 1.240(0.422-3.647) 0.696
Age started smoking 0.925(0.674-1.268) 0.627
Duration of smoking 0.892(0.672-1.185) 0.430
No. of cigarettes taken per day 1.053(0.952-1.165) 0.318
Money spent on cigarette per month 1.006(1.0-1.013) 0.055
Variables Model 1OR (95% CI) p-value
Model 2
OR (95% CI) p-value
Model 3
OR (95% CI) p-value
Previous attempt to quit:
 Yes (reference)
 No
0.974(0.358-2.651) 0.959
Level of nicotine addiction (FTND):
 Low (reference)
 Mod/High
2.583(0.569-11.721) 0.219
Level of CO in lungs:
 Low/Moderate (reference)
 High
0.326(0.139-0.766) 0.010
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focus on dealing with obstacles to quitting and possible 
withdrawal symptoms. Certain situations either socially 
or psychologically may trigger them to start smoking 
again. Such situations include drinking coffee or alcoholic 
drinks, after meal time or being around smoking friends 
(Báezconde-Garbanati et al. 2011). 
 For patients who were unwilling to make a quit 
attempt the 5A’s intervention were more towards promoting 
motivation to quit (Fiore et al. 2008). These patients were 
either in the contemplation or pre-contemplation stage. 
Patients who are in the contemplation stage indicated that 
they are beginning to aware that change is necessary but is 
ambivalent about it (Biener & Abrams 1991). In order to 
increase quit attempts, motivational interviewing strategies 
using the 5R’s (relevance, risks, rewards, roadblocks and 
repetition) is effective if used for contemplators (Fiore 
et al. 2008). Smokers in the pre-contemplation stage are 
not interested in quitting and can be very defensive when 
given advice to quit (Biener & Abrams 1991). Asking 
pre-contemplators to give reasons on what would make 
them consider quitting may help them to move to the 
contemplation stage (Báezconde-Garbanati et al. 2011). 
Thus, first step of 5A’s (Ask) could be a possible initiation 
of the smoking cessation treatment on the chair-side. 
 The strength of the 5A’s intervention is explained by 
the motivation component in behaviour change method. 
The 5A’s is also consistent with MI technique which 
focuses on exploring a smokers’ feelings, beliefs, ideas, 
and values on tobacco use to uncover any ambivalence 
about tobacco use (Fiore et al. 2008). When these theories 
were discussed with the clinicians, the reasons, ideas, and 
needs to eliminate tobacco use may initiate an action to 
change smoking behaviour. The components of steps- 
Assess, Assist and Arrange in the 5A’s were the extra 
strength that BA do not have. Combining self-regulation 
and social support involving families, friends or colleagues 
are important to increase their motivation to quit smoking 
(Ochsner at al. 2014). 
 In this study, findings show that BA was not delivered 
as extensive as the 5A’s regardless of the motivational 
component that both had to change behaviour. Although, 
a recent Cochrane review by Stead et al. (2013) suggested 
that providing a follow-up appointment may increase the 
effect, however our study shows otherwise. Despite the 
same number of follow-ups given to participants in both 
interventions, only about a third quit smoking with BA. 
However, researchers found that BA is effective for smokers 
who are strongly motivated to quit (Coleman 2004; Fiore 
et al. 2008). Thus, BA intervention may be a preferable 
option as the first treatment option since it is cheaper and 
less time consuming, although the effect might not be 
equivalent as of 5A’s (Stead et al. 2013). In his review, 
Stead et al. (2013) also pointed out that the proportion of 
physicians offering advice to quit is more important and 
provides greater public health benefits. Thus, BA could be 
suggested as a treatment for smoking cessation integrated 
with other dental treatments treating smoking-related 
oral diseases or conditions in the primary dental care. 
Studies have shown that brief advice is one of the most 
cost-effective interventions in medicine and is shown to 
be an effective means of smoking cessation in smokers 
with established smoking-related disease (Coleman 2004; 
Lancaster & Stead 2005; West et al. 2015). Moreover, West 
et al. (2015) analysed in his review that BA from a trained 
health care worker can have a small but important effect in 
promoting smoking cessation in any health-care system. 
 There were several limitations that needed to be 
addressed. The recruitment of Dental Public Health (DPH) 
specialists was considered for this study due to the high 
turnover rate of general dentists in the health system. The 
smoking cessation provider needs to be to be allocated at 
the designated dental clinic for at least one year during 
the trial period. The age range and years of clinical 
experience of the DPH specialists were almost similar. This 
will minimise the variations in counselling patients. In 
reality, the variation in personality traits of the specialist or 
dentists may affect the outcomes of the counselling. Future 
study may want to look for information on how dentists’ 
personality characteristics may be effect the success of 
smoking intervention. 
 There were problems in contacting the patients for 
their follow-ups. Patients were not easily contactable or 
had to be contacted more than twice for the follow-ups to 
be done. Some patients requested to be contacted at odd 
hours away from the time allocated for the investigators to 
conduct the follow-ups via telephone calls. Some patients 
tend to provide their telephone numbers, answered the 
first follow-up call, but were reluctant to answer the next 
time. Again, if an appointment were given to them for 
their 6-month follow-up, some failed to attend. Thus, our 
inability to recruit patients as expected and to deliver the 
full intervention to patients who did enrol raises important 
issues and a cautionary note for future research and 
intervention. 
 In conclusion, dentists are well positioned to influence 
smokers to quit regardless of either by the used of 5A’s 
or BA in smoking cessation intervention. The components 
of steps- Assess, Assist and Arrange in the 5A’s were the 
extra strength that BA do not have. During the steps- Assess 
and Assist, the counselling technique in 5A’s focuses on 
discovering smokers’ feelings, beliefs, ideas and values on 
tobacco use to discover any ambivalence about tobacco 
use (Fiore et al. 2008). Therefore, the reasons, ideas and 
needs to eliminate tobacco use may initiate an action to 
change a person’s smoking behaviour. Thus, the 5A’s model 
should be offered to those who are unable to quit upon BA 
intervention and needed an additional intense motivational 
intervention. 
 BA intervention may be a preferable option as the first 
treatment option integrated with other dental treatments 
treating smoking-related oral diseases or conditions in 
the primary dental care since it is cheaper and less time 
consuming. Stead et al. (2013) discussed that the proportion 
of physicians offering advice to quit is more important and 
provides more public health benefits. This was supported 
by West et al. (2015) which also agree that BA from a 
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trained health care worker may be insignificant but has an 
important effect in promoting smoking cessation in any 
health-care system. Studies have shown that brief advice 
is one of the most cost-effective interventions in medicine 
and is shown to be an effective means of smoking cessation 
in smokers with established smoking-related disease 
(Coleman 2004; Lancaster & Stead 2005). Thus, this may 
well be applied to smoking-related oral diseases too.
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